Georgieva A M, van Greevenbroek M M J, Krauss R M, Brouwers M C G J, Vermeulen V M M-J, Robertus-Teunissen M G, van der Kallen C J H, de Bruin T W A
Cardiovascular Research Institute Maastricht, Laboratory of Molecular Metabolism and Endocrinology, Department of Medicine, University of Maastricht, The Netherlands.
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):744-9. doi: 10.1161/01.ATV.0000119681.47218.a4. Epub 2004 Jan 29.
The present study addresses the presence of distinct metabolic phenotypes in familial combined hyperlipidemia (FCHL) in relation to small dense low-density lipoprotein (sd LDL) and very low-density lipoprotein (VLDL) subclasses.
Hyperlipidemic FCHL relatives (n=72) were analyzed for LDL size by gradient gel electrophoresis. Pattern B LDL (sd LDL, particle size <258 A) and pattern A LDL (buoyant LDL, particle size > or =258 A) were defined. Analyses showed bimodal distribution of LDL size associated with distinct phenotypes. Subjects with predominantly large, buoyant LDL showed a hypercholesterolemic phenotype and the highest apo B levels. Subjects with predominantly sd LDL showed a hypertriglyceridemic, low high-density lipoprotein (HDL) cholesterol phenotype, with moderately elevated apoB, total cholesterol level, and LDL cholesterol level. Subjects with both buoyant LDL and sd LDL (pattern AB, n=7) showed an intermediate phenotype, with high normal plasma triglycerides. VLDL subfraction analysis showed that the sd LDL phenotype was associated with a 10-times higher number of VLDL1 particles of relatively lower apo AI and apo E content, as well as smaller VLDL2 particles, in combination with increased plasma insulin concentration in comparison to pattern A.
The present observations underscore the importance of the VLDL triglyceride metabolic pathway in FCHL as an important determinant of the phenotypic heterogeneity of the disorder.
本研究探讨家族性混合性高脂血症(FCHL)中与小而密低密度脂蛋白(sd LDL)和极低密度脂蛋白(VLDL)亚类相关的不同代谢表型的存在情况。
通过梯度凝胶电泳对72名高脂血症FCHL亲属的低密度脂蛋白大小进行分析。定义了B型低密度脂蛋白(sd LDL,颗粒大小<258 Å)和A型低密度脂蛋白(漂浮性低密度脂蛋白,颗粒大小≥258 Å)。分析显示低密度脂蛋白大小的双峰分布与不同表型相关。主要为大的、漂浮性低密度脂蛋白的受试者表现出高胆固醇血症表型和最高的载脂蛋白B水平。主要为sd LDL的受试者表现出高甘油三酯血症、低高密度脂蛋白(HDL)胆固醇表型,载脂蛋白B、总胆固醇水平和低密度脂蛋白胆固醇水平中度升高。同时具有漂浮性低密度脂蛋白和sd LDL(AB型,n = 7)的受试者表现出中间表型,血浆甘油三酯水平高正常。VLDL亚组分分析显示,与A型相比,sd LDL表型与数量多10倍的相对较低载脂蛋白AI和载脂蛋白E含量的VLDL1颗粒以及较小的VLDL2颗粒相关,同时血浆胰岛素浓度升高。
本观察结果强调了VLDL甘油三酯代谢途径在FCHL中作为该疾病表型异质性的重要决定因素的重要性。